Patient on $50,000-a-Week Cancer Drug Fears Leaving Behind Huge Medical Debt

After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the

Related Keywords

Texas ,United States ,Columbus ,Ohio ,White House ,District Of Columbia ,Sebastien Desprez ,Merith Basey ,Lamy Leach ,Stacie Dusetzina ,Paul Davis ,Arthurg James ,Hagop Kantarjian ,Elizabeth Moreno ,Vanderbilt University Medical Center ,Department Of Leukemia ,Blanchard Valley Health System In Findlay ,Md Anderson Cancer Center ,Blanchard Valley Health System ,Cancer Hospital ,Blanchard Valley ,Valley Health System ,England Based Immunocore ,Cancer Center ,Affordable Drugs ,Trade ,Medicine ,He Economy ,Inance ,Harmacology ,Ncology ,Advertising ,Jaw ,Accounting ,Health Care ,